Company: ABBV
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0001551152-25-000049
Chunk: 58

Company: AbbVie Inc.
Filing Date: 2025-11-04
Form: 10-Q
Item: Part I, Item 1
Chunk 58
---
aboration revenues$44 $31 $129 $82 International25 12 61 24 Total$69 $43 $190 $106 Other OncologyUnited States$11 $— $13 $— AestheticsBotox CosmeticUnited States$379 $414 $1,084 $1,253 International258 257 801 780 Total$637 $671 $1,885 $2,033 Juvederm CollectionUnited States$98 $105 $278 $349 International155 153 466 549 Total$253 $258 $744 $898 Other AestheticsUnited States$265 $272 $817 $828 International38 38 128 119 Total$303 $310 $945 $947 Eye CareOzurdexUnited States$32 $33 $92 $102 International85 86 273 272 Total$117 $119 $365 $374 Lumigan/GanfortUnited States$42 $58 $142 $129 International55 58 164 181 Total$97 $116 $306 $310 Alphagan/CombiganUnited States$9 $26 $35 $54 International38 36 108 116 Total$47 $62 $143 $170 Other Eye CareUnited States$138 $123 $399 $421 International110 105 316 321 Total$248 $228 $715 $742 Other Key ProductsMavyretUnited States$146 $147 $472 $458 International166 155 521 562 Total$312 $302 $993 $1,020 CreonUnited States$368 $338 $1,127 $995 Linzess/ConstellaUnited States$315 $225 $701 $693 International11 9 31 28 Total$326 $234 $732 $721 All other$660 $726 $2,010 $2,280 Total net revenues$15,776 $14,460 $44,542 $41,232 

See the following for additional information about certain income and expenses included in net earnings: